These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 6356308)

  • 21. Immune reactivity to native type II collagen in rheumatoid arthritis assessed by the leukocyte adherence inhibition assay and radioimmunoassay.
    Tannenbaum H; Clague RB; Holt PJ; Wild J
    Clin Invest Med; 1982; 5(4):231-5. PubMed ID: 7160110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoantibodies against granulocyte colony-stimulating factor in Felty's syndrome and neutropenic systemic lupus erythematosus.
    Hellmich B; Csernok E; Schatz H; Gross WL; Schnabel A
    Arthritis Rheum; 2002 Sep; 46(9):2384-91. PubMed ID: 12355486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
    Russo K; Hoch S; Dima C; Varga J; Teodorescu M
    J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating autoantibodies to IgD in rheumatic diseases.
    Pope RM; Keightley R; McDuffy S
    J Immunol; 1982 Apr; 128(4):1860-3. PubMed ID: 6977573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
    Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
    Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoantibodies to lipoprotein lipase and dyslipidemia in systemic lupus erythematosus.
    Reichlin M; Fesmire J; Quintero-Del-Rio AI; Wolfson-Reichlin M
    Arthritis Rheum; 2002 Nov; 46(11):2957-63. PubMed ID: 12428237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IgG antibodies to type II collagen reflect inflammatory activity in patients with rheumatoid arthritis.
    Kim WU; Yoo WH; Park W; Kang YM; Kim SI; Park JH; Lee SS; Joo YS; Min JK; Hong YS; Lee SH; Park SH; Cho CS; Kim HY
    J Rheumatol; 2000 Mar; 27(3):575-81. PubMed ID: 10743792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rheumatoid arthritis and its association with HLA-DR antigens. I. Cell mediated immune response against connective tissue antigens.
    Vullo CM; Pesoa SA; Onetti CM; Riera CM
    J Rheumatol; 1987 Apr; 14(2):221-5. PubMed ID: 3598992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical relevance of the antiphospholipid syndrome. Antiphospholipid antibodies in a mixed rheumatologic patient sample].
    Kühne C; Keitel W; Flach W
    Fortschr Med; 1994 Oct; 112(30):423-6. PubMed ID: 7806118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Catalytic autoantibodies as a new molecular instrument in rheumatological practice].
    Khitrov AN; Mal'tsev KA; Vvedenskaia OIu; Ponomarenko NA; Isaeva MA; Kimova MV; Tret'iak EB; Shogenov ZS; Alekberova ZS; Gabibov AG; Suchkov SV
    Ter Arkh; 2006; 78(6):59-66. PubMed ID: 16881365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are there autoantibodies reacting against citrullinated peptides derived from type I and type II collagens in patients with rheumatoid arthritis?
    Koivula MK; Aman S; Karjalainen A; Hakala M; Risteli J
    Ann Rheum Dis; 2005 Oct; 64(10):1443-50. PubMed ID: 16162901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic, prognostic and therapeutic aspects of systemic lupus erythematosus and rheumatoid arthritis.
    Weyand C
    Klin Wochenschr; 1990; 68 Suppl 21():55-63. PubMed ID: 2198390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoantibodies against galectin-8: their specificity, association with lymphopenia in systemic lupus erythematosus and detection in rheumatoid arthritis and acute inflammation.
    Massardo L; Metz C; Pardo E; Mezzano V; Babul M; Jarpa E; Guzmán AM; André S; Kaltner H; Gabius HJ; Jacobelli S; González A; Soza A
    Lupus; 2009 May; 18(6):539-46. PubMed ID: 19395456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
    Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S
    J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A novel method for screening anti-inner ear autoantibody in patients with autoimmune diseases].
    Zou J; Bi A; Wu X; Yang W; Li Z
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2000 Apr; 35(2):113-6. PubMed ID: 12768666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fas promoter -670 polymorphism is associated with development of anti-RNP antibodies in systemic lupus erythematosus.
    Lee YH; Kim YR; Ji JD; Sohn J; Song GG
    J Rheumatol; 2001 Sep; 28(9):2008-11. PubMed ID: 11550967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between protein tyrosine phosphatase 22 variant R620W in conjunction with the HLA-DRB1 shared epitope and humoral autoimmunity to an immunodominant epitope of cartilage-specific type II collagen in early rheumatoid arthritis.
    Burkhardt H; Hüffmeier U; Spriewald B; Böhm B; Rau R; Kallert S; Engström A; Holmdahl R; Reis A
    Arthritis Rheum; 2006 Jan; 54(1):82-9. PubMed ID: 16385499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serial analysis of autoantibody responses to the collagen-like region of Clq, collagen type II, and double stranded DNA in patients with systemic lupus erythematosus.
    Sjoholm AG; Martensson U; Sturfelt G
    J Rheumatol; 1997 May; 24(5):871-8. PubMed ID: 9150075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular sensitivity to collagen in rheumatoid arthritis.
    Trentham DE; Dynesius RA; Rocklin RE; David JR
    Trans Assoc Am Physicians; 1978; 91():118-28. PubMed ID: 754387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biological markers in inflammatory rheumatic diseases.
    Hilliquin P
    Cell Mol Biol (Noisy-le-grand); 1995 Dec; 41(8):993-1006. PubMed ID: 8747080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.